NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neobe Therapeutics

Neobe Therapeutics

Private
CambridgeHealthcare & Life Scienceshttps://www.neobetherapeutics.com/

Last Round

Seed

Feb 29, 2024

Total Funding Raised

$2.96M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Neobe Therapeutics is a biotechnology company developing a synthetic biology platform to engineer programmable bacteria that remodel the microenvironment of solid tumors to improve immunotherapy efficacy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

live biotherapeuticssynthetic biologyLBPtumor microenvironmentsynbiocancer immunotherapyengineered bacteriasolid tumor treatmentmicrobial therapeuticsdrug discovery platformbacterial cancer therapygenetic circuit designimmuno-oncologybiotech startupbacterial trojan horse

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neobe Therapeutics Comparables

Compare Neobe Therapeutics with similar companies based on industry and business-model similarity.

Neobe Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prokarium
85%
Baccine Ltd.
81%
Laguna Bio
77%

Neobe Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 29, 2024
Pre SeedNov 22, 2022

Neobe Therapeutics Investors

Notable investors and investment history

Neobe Therapeutics investors
InvestorRounds
Deep Science VenturesSeed
Pioneer GroupSeed
Innovate UKSeed, Pre Seed
2048 VenturesSeed
Cancer Research HorizonsSeed
Discovery Park VenturesSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors increased 51% MoM.

Neobe Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neobe Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neobe Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range12
Year Founded2021
Last FundingFeb 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.